Search research articles
Contact Us
Filters
Showing results (71-80 of 621) with videos related to
Page
of 63
Sort By:
The New England Journal of Medicine
|
April 25, 2009
More on reports of esophageal cancer with oral bisphosphonate use
Daniel H Solomon, Amanda Patrick, M Alan Brookhart
Nature Reviews. Rheumatology
|
March 25, 2015
Active-comparator design and new-user design in observational studies
Kazuki Yoshida, Daniel H Solomon, Seoyoung C Kim
Annals of the Rheumatic Diseases
|
April 23, 2013
The risk of atrial fibrillation in patients with rheumatoid arthritis
Seoyoung C Kim, Jun Liu, Daniel H Solomon
American Journal of Epidemiology
|
April 12, 2017
Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases
Jessica M Franklin, Sebastian Schneeweiss, Daniel H Solomon
Arthritis Care & Research
|
February 22, 2023
Clinical Visit Frequencies in Rheumatology: A Systematic Literature Review
Yuxuan Jiang, Robert S Rudin, Daniel H Solomon
Rheumatic Diseases Clinics of North America
|
November 24, 2019
Education and Professional Development in Rheumatology: Translating Quality Improvement and Education to Clinical Practice
Christina Downey, Deepa Ragesh Panikkath, Daniel H Solomon
The Journal of Clinical Endocrinology and Metabolism
|
October 26, 2019
Reply to Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use"
Houchen Lyu, Sizheng S Zhao, Daniel H Solomon
Annals of the Rheumatic Diseases
|
September 2, 2015
Risk of incident atrial fibrillation in gout: a cohort study
Seoyoung C Kim, Jun Liu, Daniel H Solomon
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 22, 2014
Risk of incident diabetes in patients with gout: a cohort study
Seoyoung C Kim, Jun Liu, Daniel H Solomon
Current Opinion in Rheumatology
|
January 5, 2021
Medications for gout and its comorbidities: mutual benefits?
Kazuki Yoshida, Hyon K Choi, Daniel H Solomon
Page
of 63
Search research articles
Search
Showing results (71-80 of 621) with videos related to
Sort By:
Page
of 63
The New England Journal of Medicine
|
April 25, 2009
More on reports of esophageal cancer with oral bisphosphonate use
Daniel H Solomon, Amanda Patrick, M Alan Brookhart
Nature Reviews. Rheumatology
|
March 25, 2015
Active-comparator design and new-user design in observational studies
Kazuki Yoshida, Daniel H Solomon, Seoyoung C Kim
Annals of the Rheumatic Diseases
|
April 23, 2013
The risk of atrial fibrillation in patients with rheumatoid arthritis
Seoyoung C Kim, Jun Liu, Daniel H Solomon
American Journal of Epidemiology
|
April 12, 2017
Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases
Jessica M Franklin, Sebastian Schneeweiss, Daniel H Solomon
Arthritis Care & Research
|
February 22, 2023
Clinical Visit Frequencies in Rheumatology: A Systematic Literature Review
Yuxuan Jiang, Robert S Rudin, Daniel H Solomon
Rheumatic Diseases Clinics of North America
|
November 24, 2019
Education and Professional Development in Rheumatology: Translating Quality Improvement and Education to Clinical Practice
Christina Downey, Deepa Ragesh Panikkath, Daniel H Solomon
The Journal of Clinical Endocrinology and Metabolism
|
October 26, 2019
Reply to Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use"
Houchen Lyu, Sizheng S Zhao, Daniel H Solomon
Annals of the Rheumatic Diseases
|
September 2, 2015
Risk of incident atrial fibrillation in gout: a cohort study
Seoyoung C Kim, Jun Liu, Daniel H Solomon
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 22, 2014
Risk of incident diabetes in patients with gout: a cohort study
Seoyoung C Kim, Jun Liu, Daniel H Solomon
Current Opinion in Rheumatology
|
January 5, 2021
Medications for gout and its comorbidities: mutual benefits?
Kazuki Yoshida, Hyon K Choi, Daniel H Solomon
Page
of 63